Company Filing History:
Years Active: 2017
Title: Yanli Mi - Innovator in Cardiovascular Treatments
Introduction
Yanli Mi is a notable inventor based in San Mateo, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular and cerebrovascular disorders. His innovative work has led to the development of a unique composition that enhances the efficacy of existing treatments.
Latest Patents
Yanli Mi holds 1 patent for his invention titled "Compositions of nicardipine and sulfoalkylated β-cyclodextrin." This patent describes compositions that include an inclusion complex of nicardipine or a pharmaceutically acceptable salt thereof, combined with sulfoalkylated β-cyclodextrin. The formulations are designed for parenteral bolus administration to human subjects, providing a new avenue for effective treatment in cardiovascular health.
Career Highlights
Yanli Mi is currently associated with Ekr Therapeutics, Inc., where he continues to advance his research and development efforts. His work focuses on creating innovative solutions that address critical health issues, particularly in the cardiovascular domain.
Collaborations
Yanli Mi collaborates with talented professionals in his field, including Supriya Gupta and Camellia Zamiri. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Yanli Mi's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in healthcare. His patent for compositions aimed at treating cardiovascular disorders showcases his commitment to improving patient outcomes.